Literature DB >> 6741123

The design of rational combination chemotherapy for cancer.

E C Cadman.   

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Drs Homer A. Boushey, Associate Professor of Medicine, and David G. Warnock, Associate Professor of Medicine, under the direction of Dr Lloyd H. Smith, Jr, Professor of Medicine and Chairman of the Department of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6741123      PMCID: PMC1011130     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  19 in total

1.  Effects of A-methopterin on the purine biosynthesis of susceptible and resistant TA3 ascites cells.

Authors:  A C SARTORELLI; G A LEPAGE
Journal:  Cancer Res       Date:  1958-12       Impact factor: 12.701

2.  DNA glycosylases, endonucleases for apurinic/apyrimidinic sites, and base excision-repair.

Authors:  T Lindahl
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1979

3.  Rapid formation of poly-gamma-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro.

Authors:  D W Fry; J C Yalowich; I D Goldman
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

Review 4.  Perspective on the design and biochemical pharmacology of inhibitors of thymidylate synthetase.

Authors:  D V Santi
Journal:  J Med Chem       Date:  1980-02       Impact factor: 7.446

5.  Tight binding inhibitors--IX. Kinetic parameters of dihydrofolate reductase inhibited by methotrexate, an example of equilibrium study.

Authors:  S Cha; S Y Kim; S G Kornstein; P W Kantoff; K H Kim; F N Naguib
Journal:  Biochem Pharmacol       Date:  1981-06-15       Impact factor: 5.858

Review 6.  On the nature of thymineless death.

Authors:  S S Cohen
Journal:  Ann N Y Acad Sci       Date:  1971-11-30       Impact factor: 5.691

7.  Tamoxifen and 5-fluorouracil in breast cancer: modulation of cellular RNA.

Authors:  C Benz; G Santos; E Cadman
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

8.  Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer.

Authors:  C Benz; T Tillis; E Tattelman; E Cadman
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

9.  Use of high-dose oral methotrexate sequenced at 24 hours with 5-FU: a clinical toxicity study.

Authors:  C Benz; M Silverberg; E Cadman
Journal:  Cancer Treat Rep       Date:  1983-03

10.  Evaluation of ribonucleoside and deoxyribonucleoside triphosphate pools in cultured leukemia cells during exposure to methotrexate or methotrexate plus thymidine.

Authors:  J J Kinahan; M Otten; G B Grindey
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.